您的购物车中没有商品。

Generic and Innovator Drugs: A Guide to FDA Approval Requirements, Seventh Edition

Generic and Innovator Drugs: A Guide to FDA Approval Requirements, 8th Edition (1-year Online Subscription)

  • 作者:
  • 出版商: Wolters Kluwer Legal & Regulatory U.S. (Online)
  • ISBN: 10066263
  • 出版时间 Subscription-type (Contents updated periodically)
  • 规格: Online , 1676 pages
  • 适应领域: U.S. ? 免责申明:
    Countri(es) stated herein are used as reference only
¥7,212.67
发货时间:大约 2-3 working days
Extra 2-10 working days if shipping address outside Hong Kong
Free delivery Hong Kong?
Hong Kong: free delivery (order over HKD 1000)
  • 描述 
  • 大纲 
  • 详细

    Completely updated, the new Eighth Edition of Generic and Innovator Drugs: A Guide to FDA Approval Requirements provides indispensable and practical insights into the FDA approval process.

    You’ll find comprehensive coverage of:

    • Abbreviated new drug applications
    • 505(b)(2) new drug applications
    • Delaying approval of competing products
    • FDA approval of biologic drugs

    No other book can cover the drug approval process as thoroughly, answering important questions like these:

    • What is required to extend the patent of an FDA-approved product?
    • When must a generic manufacturer notify the innovator manufacturer when submitting an ANDA or 505(b)(2) application?
    • When does the FDA delay approvals because of patent claims, and when does it ignore patents?
    • How can one challenge an FDA exclusivity decision?
    • When can a manufacturer safely sell a drug without prior FDA approval?
    • In what circumstances can a generic manufacturer obtain FDA permission to file an ANDA for a variant of an existing drug?
    • When will the FDA waive or reduce prescription drug user fees?
    • How can a company or an individual avoid debarment?
    • What steps are necessary to comply with the FDA’s Fraud Policy?
    • When and how can a drug company take advantage of FDA accelerated approval procedures?
    • What are the labeling requirements for exporting approved drugs?
    • How have the changes made by the FDA Safety and Innovation Act, including the Prescription Drug User Fee Act, the Generic Drug User Fee Amendments and the Biosimilars User Fee Act, and the Generating Antibiotic Incentives Now Act affected the overall statutory scheme?

    Generic and Innovator Drugs: A Guide to FDA Approval Requirements, Eighth Edition provides step-by-step guidance of the approval process and expert interpretation of:

    • The Hatch-Waxman Act (Drug Price Competition and Patent Restoration Act)
    • The Medicare Prescription Drug, Improvement, and Modernization Act
    • The Food and Drug Administration Modernization Act
    • The FDA Export Reform and Enhancement Act
    • The Biologics Price Competition and Innovation Act
    • And more!

    AUTHOR NOTE: Donald O. Beers’ contributions to this publication were completed before he rejoined the Food and Drug Administration. He has had no part in writing and revising this Eighth Edition.

  • Chapter 1. FDA APPROVAL REQUIREMENT

    • 1.01 Marketing New Drugs; General Requirements
    • 1.02 Marketing New Drugs without FDA Approval
    • 1.03 Application of New Drug Definition to Generic Products
    • 1.04 Escaping New Drug Status
    • 1.05 Determination of New Drug Status
    • 1.06 FDA Enforcement Policy

    Chapter 2. FULL NEW DRUG APPLICATIONS

    • 2.01 Generally
    • 2.02 New Drug Applications—Content
    • 2.03 New Drug Applications—Procedure
    • 2.04 Supplemental New Drug Applications
    • 2.05 New Drug Applications—Withdrawal of Approval
    • 2.06 New Drug Applications—Suspension of Approval

    Chapter 3. ABBREVIATED NEW DRUG APPLICATIONS AND “505(b)(2) APPLICATIONS”

    • 3.01 Generally
    • 3.02 Abbreviated New Drug Applications under 505(j); Qualifying Drugs
    • 3.03 Abbreviated New Drug Applications under 505(j); Contents
    • 3.04 Abbreviated New Drug Applications under 505(j); Procedure
    • 3.05 505(b)(2) Applications

    Chapter 4. DELAYING APPROVAL OF COMPETITIVE PRODUCTS

    Chapter 5. PUBLIC AVAILABILITY OF DRUG AND BIOLOGIC DATA

    • 5.01 Pending Applications
    • 5.02 Safety and Effectiveness Data
    • 5.03 Information Concerning ANDA Approval Process

    Chapter 6. POTENTIAL FOR GOVERNMENT COMPENSATION

    Chapter 7. THE ORPHAN DRUG AMENDMENTS

    • 7.01 Orphan Drug Designation
    • 7.02 Orphan Drug Exclusivity
    • 7.03 Other Benefits of Designation

    Chapter 8. DEBARMENT AND CIVIL PENALTIES

    • 8.01 Background
    • 8.02 Overview
    • 8.03 Debarment
    • 8.04 Civil Penalties—GDEA
    • 8.05 Civil Penalties—Other
    • 8.06 Suspension of Right to Distribute

    Chapter 9. FDA FRAUD POLICY

    • 9.01 Generally
    • 9.02 Applicability and Effect
    • 9.03 Actions Required
    • 9.05 Internal Reviews and Corrective Action Plans
    • 9.06 Validity of the Fraud Policy

    Chapter 10. EXPANDED ACCESS TO INVESTIGATIONAL DRUGS AND ACCELERATED APPROVALS

    • 10.01 Background
    • 10.02 Expanded Access to Investigational Drugs for Treatment Use
    • 10.03 Expedited Approval Procedure

    Chapter 11. EXPORT AND IMPORT REQUIREMENTS

    • 11.01 Introduction
    • 11.02 Export Requirements
    • 11.03 Imports

    Chapter 12. PRESCRIPTION DRUG AND BIOLOGIC USER FEES

    • 12.01 Introduction
    • 12.02 Types of User Fees
    • 12.03 Waivers, Reductions, and Refunds
    • 12.04 Failure to Pay Fees
    • 12.05 Condition for Continuation of Fees
    • 12.06 User Fee Invoicing
    • 12.07 The Quid Pro Quo: FDA Commitments
    • 12.08 Conclusion

    Chapter 13. FDA APPROVAL OF BIOLOGIC DRUGS

你可能需要

The Hong Kong Company Secretary's Handbook: Practice and Procedure (11th Edition)
The Hong Kong Company Secretary's Handbook: Practice and Procedure (11th Edition)

List Price: ¥497.55

¥482.62 Save ¥14.93 (3%)

Hong Kong Tax & Accounting Practical Toolkit (Basic Package)
Hong Kong Tax & Accounting Practical Toolkit (Basic Package)
¥3,161.07
Hong Kong Company Secretary Checklist, 2nd Edition
Hong Kong Company Secretary Checklist, 2nd Edition

List Price: ¥1,283.40

¥1,244.90 Save ¥38.50 (3%)

Law of Companies in Hong Kong, 4th Edition (Hardcopy + e-Book)
Law of Companies in Hong Kong, 4th Edition (Hardcopy + e-Book)

List Price: ¥3,255.00

¥3,157.35 Save ¥97.65 (3%)

Butterworths Hong Kong Discrimination Law Handbook, 4th Edition
Butterworths Hong Kong Discrimination Law Handbook, 4th Edition

List Price: ¥1,395.00

¥1,353.15 Save ¥41.85 (3%)

Sentencing in Hong Kong, 11th Edition
Sentencing in Hong Kong, 11th Edition

List Price: ¥3,329.40

¥3,229.52 Save ¥99.88 (3%)

Butterworths Hong Kong Company Law (Winding-Up and Miscellaneous Provisions) Handbook, 6th Edition
Butterworths Hong Kong Company Law (Winding-Up and Miscellaneous Provisions) Handbook, 6th Edition

List Price: ¥2,120.40

¥2,056.79 Save ¥63.61 (3%)

Butterworths Hong Kong Company Law Handbook, 26th Edition
Butterworths Hong Kong Company Law Handbook, 26th Edition

List Price: ¥4,092.00

¥3,969.24 Save ¥122.76 (3%)

Cross-Border Crime in Hong Kong: Extradition, Mutual Assistance & Financial Sanctions, 3rd Edition
Cross-Border Crime in Hong Kong: Extradition, Mutual Assistance & Financial Sanctions, 3rd Edition

List Price: ¥1,934.40

¥1,876.37 Save ¥58.03 (3%)

Clough & Clough on Personal Injuries
Clough & Clough on Personal Injuries

List Price: ¥1,395.00

¥1,353.15 Save ¥41.85 (3%)

Hong Kong Personal Insolvency Manual, 3rd Edition
Hong Kong Personal Insolvency Manual, 3rd Edition

List Price: ¥1,860.00

¥1,804.20 Save ¥55.80 (3%)

Butterworths Hong Kong Conveyancing and Property Law Handbook, 6th Edition
Butterworths Hong Kong Conveyancing and Property Law Handbook, 6th Edition

List Price: ¥1,674.00

¥1,623.78 Save ¥50.22 (3%)

A Practical Guide to Resolving Shareholder Disputes, 2nd Edition
A Practical Guide to Resolving Shareholder Disputes, 2nd Edition

List Price: ¥1,674.00

¥1,623.78 Save ¥50.22 (3%)

Tort Law in Hong Kong, 5th Edition (Hardcopy + ebook)
Tort Law in Hong Kong, 5th Edition (Hardcopy + ebook)

List Price: ¥2,325.00

¥2,255.25 Save ¥69.75 (3%)

Company Law in Hong Kong: Practice and Procedure 2023 (Hardcopy + e-Book)
Company Law in Hong Kong: Practice and Procedure 2023 (Hardcopy + e-Book)

List Price: ¥2,974.14

¥2,884.92 Save ¥89.22 (3%)

Company Law in Hong Kong: Insolvency 2023 (Hardcopy + e-Book)
Company Law in Hong Kong: Insolvency 2023 (Hardcopy + e-Book)

List Price: ¥2,643.99

¥2,564.67 Save ¥79.32 (3%)

Hong Kong Company Law, 15th Edition
Hong Kong Company Law, 15th Edition

List Price: ¥457.56

¥443.83 Save ¥13.73 (3%)

Private Equity in Hong Kong and China, 4th Edition
Private Equity in Hong Kong and China, 4th Edition

List Price: ¥1,860.00

¥1,804.20 Save ¥55.80 (3%)

Hong Kong Family Court Practice, 4th Edition
Hong Kong Family Court Practice, 4th Edition

List Price: ¥2,511.00

¥2,435.67 Save ¥75.33 (3%)

Brooke's Notary Hong Kong, 3rd Edition
Brooke's Notary Hong Kong, 3rd Edition

List Price: ¥1,581.00

¥1,533.57 Save ¥47.43 (3%)